Announced
Completed
AFFERENT PHARMACEUTICALS INC / MERCK & CO / THIRD ROCK VENTURES LLC / TEKLA CAPITAL MANAGEMENT LLC / NEW LEAF VENTURE PARTNERS / DOMAIN ASSOCIATES LLC / A M PAPPAS & ASSOCIATES / Acquisition / Private / £859m
Synopsis
Sale of Afferent Pharmaceuticals, a developer of pharmaceutical treatments for osteoarthritis, back pain, visceral pain and neuropathy, to Merck & Co.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
All rights reserved. Copyright © 2025 Datasite